GSK
706 hedge funds and large institutions have $8.53B invested in GSK in 2015 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 261 increasing their positions, 264 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
706
Holders Change
-13
Holders Change %
-1.81%
% of All Funds
19.73%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.25%
New
46
Increased
261
Reduced
264
Closed
51
Calls
$182M
Puts
$115M
Net Calls
+$66.7M
Net Calls Change
+$63M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$181M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$86.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$77.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$70.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$50M |
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$472M |
| 2 |
D.E. Shaw & Co
New York
|
-$74.9M |
| 3 |
Renaissance Technologies
New York
|
-$69.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$65.8M |
| 5 |
Barclays
London,
United Kingdom
|
-$35.8M |
